This care should include close attention to the possibility of TB treatment failure, antiretroviral treatment failure, paradoxical reactions of TB, unique and synergistic side effects for all drugs used, and drug toxicities associated with increased serum concentrations of rifamycins. Glaxo Wellcome Inc. Abacavir package insert. Glaxo Wellcome Inc., 1998. Benedek IH, Joshi A, Fiske WD, et al. Norvir package insert.
Ritonavir enables combined therapy with rifampin and saquinavir.
Seguin I, et al. Targeted tuberculin testing and treatment of latent tuberculosis infection. Table 1 Return to top. This conversion may have resulted in character translation or format errors in the HTML version. Contact GPO for current prices.